RSCM
Rock Springs Capital Management’s Theravance Biopharma TBPH Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-687,500
| Closed | -$5.09M | – | 147 |
|
|
2021
Q3 | $5.09M | Hold |
687,500
| – | – | 0.11% | 126 |
|
|
2021
Q2 | $9.98M | Buy |
687,500
+4,900
| +0.7% | +$71.2K | 0.2% | 114 |
|
|
2021
Q1 | $13.9M | Buy |
682,600
+4,400
| +0.6% | +$89.8K | 0.3% | 91 |
|
|
2020
Q4 | $12.1M | Sell |
678,200
-145,818
| -18% | -$2.59M | 0.26% | 104 |
|
|
2020
Q3 | $12.2M | Sell |
824,018
-4,200
| -0.5% | -$62.1K | 0.31% | 89 |
|
|
2020
Q2 | $17.4M | Buy |
828,218
+78,218
| +10% | +$1.64M | 0.48% | 70 |
|
|
2020
Q1 | $17.3M | Buy |
750,000
+94,800
| +14% | +$2.19M | 0.72% | 51 |
|
|
2019
Q4 | $17M | Buy |
655,200
+105,200
| +19% | +$2.72M | 0.54% | 67 |
|
|
2019
Q3 | $10.7M | Hold |
550,000
| – | – | 0.43% | 74 |
|
|
2019
Q2 | $8.98M | Hold |
550,000
| – | – | 0.32% | 82 |
|
|
2019
Q1 | $12.5M | Hold |
550,000
| – | – | 0.48% | 69 |
|
|
2018
Q4 | $14.1M | Hold |
550,000
| – | – | 0.66% | 49 |
|
|
2018
Q3 | $18M | Sell |
550,000
-102,600
| -16% | -$3.35M | 0.65% | 53 |
|
|
2018
Q2 | $14.8M | Hold |
652,600
| – | – | 0.57% | 67 |
|
|
2018
Q1 | $15.8M | Hold |
652,600
| – | – | 0.68% | 55 |
|
|
2017
Q4 | $18.2M | Buy |
652,600
+8,200
| +1% | +$229K | 0.83% | 40 |
|
|
2017
Q3 | $22.1M | Buy |
644,400
+44,400
| +7% | +$1.52M | 1.02% | 29 |
|
|
2017
Q2 | $23.9M | Hold |
600,000
| – | – | 1.21% | 22 |
|
|
2017
Q1 | $22.1M | Hold |
600,000
| – | – | 1.27% | 26 |
|
|
2016
Q4 | $19.1M | Hold |
600,000
| – | – | 1.28% | 25 |
|
|
2016
Q3 | $21.7M | Sell |
600,000
-100,000
| -14% | -$3.62M | 1.36% | 24 |
|
|
2016
Q2 | $15.9M | Buy |
700,000
+49,500
| +8% | +$1.12M | 1.18% | 25 |
|
|
2016
Q1 | $12.2M | Buy |
650,500
+5,500
| +0.9% | +$103K | 1.02% | 30 |
|
|
2015
Q4 | $10.6M | Buy |
645,000
+42,500
| +7% | +$697K | 0.8% | 43 |
|
|
2015
Q3 | $6.62M | Buy |
602,500
+127,500
| +27% | +$1.4M | 0.54% | 66 |
|
|
2015
Q2 | $6.19M | Buy |
475,000
+101,000
| +27% | +$1.32M | 0.45% | 77 |
|
|
2015
Q1 | $6.49M | Buy |
374,000
+84,000
| +29% | +$1.46M | 0.61% | 57 |
|
|
2014
Q4 | $4.33M | Buy |
290,000
+134,500
| +86% | +$2.01M | 0.51% | 61 |
|
|
2014
Q3 | $3.58M | Buy |
155,500
+105,500
| +211% | +$2.43M | 0.55% | 56 |
|
|
2014
Q2 | $1.59M | Buy |
+50,000
| New | +$1.59M | 0.29% | 74 |
|